People: Boston Scientific Corp (BSX)

BSX on New York Consolidated

9.40USD
19 Jun 2013
Price Change (% chg)

$-0.14 (-1.47%)
Prev Close
$9.54
Open
$9.57
Day's High
$9.63
Day's Low
$9.35
Volume
14,414,490
Avg. Vol
19,207,262
52-wk High
$9.75
52-wk Low
$4.79

Search Stocks

Mahoney, Michael 

Brief Biography

Mr. Michael F. Mahoney is President, Chief Executive Officer, Director of Boston Scientific Inc. He served as President of the Company from October 17, 2011 until assuming his current role. As President of the Company, he was specifically responsible for Cardiac Rhythm Management and Endoscopy (GI and Pulmonary) businesses, as well as certain corporate functions. Prior to joining the Company, he was Worldwide Chairman of the Medical Devices and Diagnostics division of Johnson & Johnson from January 2011 to September 2011 overseeing 50,000 employees and seven franchises. Prior to assuming this position, Mr. Mahoney served as Worldwide Group Chairman of Johnson & Johnson's DePuy franchise, an orthopedics and neurosciences business, from April 2007 through January 2011. From January 2001 through March 2007, Mr. Mahoney served as President and Chief Executive Officer of Global Healthcare Exchange (GHX), a provider of supply chain solutions and services that bring together hospitals, manufacturers, distributors and GPOs. Mr. Mahoney began his career at General Electric Medical Systems, where he spent 12 years, culminating in the role of General Manager of the Healthcare Information Technology business. Mr. Mahoney earned a B.B.A. in Finance from the University of Iowa and a M.B.A. from Wake Forest University.

Basic Compensation

Total Annual Compensation, USD Long-Term Incentive Plans, USD All Other, USD Fiscal Year Total, USD
2,676,000 -- 2,240,590 10,783,800

Options Compensation

  Quantity Market Value
Excercisable -- --
Unexercisable -- --
Excercised -- --
Name Fiscal Year Total

Peter Nicholas

1,265,810

Michael Mahoney

10,783,800

Jeffrey Capello

3,176,690

Timothy Pratt

2,584,840

Supratim Bose

2,331,740

Keith Dawkins

--
As Of 30 Dec 2012
Search Stocks